Respiratory Medicine
Volume 103, Issue 12 , Pages 1878-1884 , December 2009

High sensitivity C-reactive protein: Its correlation with sputum cell counts in bronchial asthma

  • Mona Hashem Allam

      Affiliations

    • Department of Chest Diseases, Faculty of Medicine, Minia University, Egypt
    • ,
  • Azza Farag Said

      Affiliations

    • Department of Chest Diseases, Faculty of Medicine, Minia University, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 0862635364.
    • ,
  • Ahmed Abd El Samie Omran

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Minia University, Egypt
    • ,
  • Dalia Mohammed Abd El-Reheim

      Affiliations

    • Department of Pathology, Faculty of Medicine, Minia University, Egypt
    • ,
  • Ahmed Hussein Kasem

      Affiliations

    • Department of Chest Diseases, Faculty of Medicine, Minia University, Egypt

Received 20 May 2008 ,Accepted 19 June 2009.

References 

  1. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212
  2. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol. 1996;156:4815–4820
  3. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high sensitivity C-reactive protein methods: implication for clinical & epidemiological application. Clin Chem. 2001;47:418–425
  4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  5. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyper responsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax. 2004;59:892–896
  6. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated hs-CRP assay. Clin Chem. 1999;45:2136–2141
  7. National Heart, Lung and Blood Institute (NHLBI). Global initiative for asthma, global strategy for asthma management and prevention revised (GINA); 2002. p. 68–78.
  8. Harik-khan RI, Fleg JI, Wise RA. Body mass index & risk of COPD. Chest. 2002;121:370–376
  9. Pin I, Gibson PG, Kolendowicz R, Gabardo G, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47:25–29
  10. Efthimiadis A, Pizzichinin E, Pizzichini MM, Hargreave FE. Sputum examination for indices of airway inflammation: laboratory procedures. Eur Respir J. 2002;19:706–708
  11. Taplin L. Malignant cells in sputum. A simple method of liquefying sputum. J Med Lab Technol. 1966;23:252
  12. In:  Bancrot JD,  Gamble M editor. Theory and practice of histological techniques. 5th ed.. Churchill Livingstone; 2002;p. 631–632
  13. Gibson PG, Wlodarczyk JW, Hensley MJ, Glesson M, Henry PL, Cripps AW, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsivness in childhood. Am J Respir Crit Care Med. 1998;158:36–41
  14. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem. 2003;49:666–669
  15. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma. 2003;40:733–739
  16. Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574–580
  17. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma from broncho-constriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745
  18. Jousilahti P, Salomaa V, Hakala K. The association of sensitive systemic inflammation markers with bronchial asthma. Immunology. 2002;89:381–385
  19. Takemura A, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006;27:908–912
  20. Anderson GP. COPD, asthma and C-reactive protein. Eur Respir J. 2006;27:874–876
  21. Doganci A, Sauer K, Karwot R, Finotto S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol. 2005;28:257–270
  22. de Torres JP, Cordoba-Lanus E, López-Aguilar C, de Fuentes M, de Garcini A, Aguirre-Jaime A, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27:902–907
  23. Nakamura H, Yamashita T. Predictive value of cardiovascular events by high sensitivity CRP. Nippon Rinsho. 2002;60:916–921
  24. Ridker PM. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  25. Visser M, Bouter LM, McQuillan GM, Wener M, Harris T. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–2135
  26. Kauffmann F, Frette C, Annes I. Relationships of haptoglobin level to FEV1, wheezing, bronchial hyper-responsiveness and allergy. Clin Exp Allergy. 1991;21:669–674
  27. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1008–1011
  28. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation sensitive plasma proteins. Circulation. 2002;106:2555–2560
  29. Gibson PG, Simpson JL, Saltas N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119:1329–1336
  30. Jayaram L, Parameswaran K, Sears M, Hargreave F. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J. 2000;16:150–158
  31. Green R, Brightling C, Woltmann G, Parker D, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57:875–879

PII: S0954-6111(09)00214-5

doi: 10.1016/j.rmed.2009.06.020

Respiratory Medicine
Volume 103, Issue 12 , Pages 1878-1884 , December 2009

Article Tools

* Image Usage & Resolution